According to Novo Integrated Sciences's latest financial reports the company's current EPS (TTM) is -$0.95. In 2022 the company made an earnings per share (EPS) of -$1.18 a decrease over its 2021 EPS that were of -$0.23.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.95 | -19.49% |
2022 | -$1.18 | 413.04% |
2021 | -$0.23 | -1.8% |
2020 | -$0.23 | 2208.27% |
2019 | -$0.01015 | -91.7% |
2018 | -$0.12 | 76.02% |
2017 | -$0.06945 | 26.09% |
2016 | -$0.05508 | -96.34% |
2015 | -$1.51 | 148.07% |
2014 | -$0.61 | -60.34% |
2013 | -$1.53 | -66.67% |
2012 | -$4.59 | -42.59% |
2011 | -$8.00 | -42.86% |
2010 | -$14.00 | -12.5% |
2009 | -$16.00 | 60% |
2008 | -$10.00 | -68.75% |
2007 | -$32.00 | 33.33% |
2006 | -$24.00 | 33.33% |
2005 | -$18.00 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Select Medical Holdings SEM | $1.60 | -268.42% | ๐บ๐ธ USA |
HealthSouth
EHC | $3.53 | -471.58% | ๐บ๐ธ USA |
Novo Integrated Sciences NVOS | -$0.95 | 0.00% | ๐บ๐ธ USA |